FDA Approves Defibrillator That Automatically Adjusts Pacing

FDA Approves Defibrillator That Automatically Adjusts Pacing

The FDA has cleared the Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan device (Medtronic) for patients with heart failure.... read more

COPD Awareness Month 2016: Atrial fibrillation, Crohn’s disease, chronic kidney disease, depression, and asthma

COPD Awareness Month 2016: Atrial fibrillation, Crohn’s disease, chronic kidney disease, depression, and asthma

November is COPD Awareness Month, so in light of this we present our articles discussing COPD and related topics, such as atrial fibrillation, Crohn’s disease, chronic kidney disease, depression, asthma, and ulcerative... read more

5 New Oral Anticoagulants for Atrial Fibrillation

5 New Oral Anticoagulants for Atrial Fibrillation

When trying to decide which therapy for nonvalvular atrial fibrillation (NVAF) is optimal for patients, many factors should be considered, including compliance, ability to perform daily activities of living, and nutrition... read more

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

In the ongoing push to understand the link between CABG surgery and new-onset atrial fibrillation, a large, multicenter registry has found that women were at lower risk of developing post-CABG A-fib.... read more

Rivaroxaban associated with increased bleeding risk compared with dabigatran in nonvalvular atrial fibrillation

Rivaroxaban associated with increased bleeding risk compared with dabigatran in nonvalvular atrial fibrillation

There was a total of 52 240 new starts of dabigatran and 66 651 new starts of rivaroxaban during the study period. Rivaroxaban was associated with a non-significant decrease in thromboembolic stroke. There was also a non-significant... read more